Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 76 (RN7SKP76) is classified as a non-coding RNA pseudogene, specifically mirroring the sequence of the functional RN7SK gene, which is a small nuclear RNA involved in transcription regulation via the 7SK ribonucleoprotein complex[5]. Pseudogenes, by definition, are genomic DNA sequences similar to normal genes but typically nonfunctional; they do not code for functional proteins or RNAs and lack known biological or therapeutic relevance[5]. Thus, RN7SKP76 is not considered a therapeutic target, does not possess defined biological functions, is not implicated in disease mechanisms, and lacks data on interacting drugs, mechanisms of action, or biomarker utility. There is no evidence supporting a direct role for RN7SKP76 in human biology or disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 76 (RN7SKP76).